We propose STRA6 expression could be related to normal retinol levels in the tumor cell cytoplasm, favoring expression of retinol nuclear receptors, and playing an essential role in NSCLC patients as improving oncological outcomes. This evidence concerns the gene STRA6 and neoplasm.